European panel supports Genzyme's Myozyme facility

02/20/2009 | Boston Globe (tiered subscription model), The

A committee of the European Commission issued a positive opinion regarding Genzyme's application to produce and market Pompe disease drug Myozyme at a Belgian manufacturing plant. The European Commission will make a final decision based on the opinion of the Committee for Medicinal Products for Human Use.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Economics & Reimbursement Manager - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA